Most Read Articles
Stephen Padilla, 6 days ago
Early administration of recombinant human B-type natriuretic peptide (rhBNP) can lower the incidence of reperfusion injury for patients with ST-elevation myocardial infarction (STEMI) who are receiving percutaneous coronary intervention (PCI) treatment, according to a China study.
11 Aug 2019
Intraoperative methylprednisolone does not appear to significantly prevent the incidence of death, cardiac arrest and other injuries in neonates undergoing cardiac surgery with cardiopulmonary bypass, according to a recent study.
3 days ago
Pulmonary function has potential predictive value for future increases in arterial stiffness and its progression, as reported in a recent study.
Yesterday
Systolic blood pressure appears to have a strong association with aneurysmal subarachnoid haemorrhage (aSAH) but not with unruptured intracranial aneurysm (UIA), whereas current smoking and female sex are risk factors for both conditions, a study has found.

Product Highlight-Skycellflu

27 Sep 2018
SKYCELLFLU – Inactivated quadrivalent influenza vaccine (inj) 0.5 mL - AJ Biologics

The World’s First Cell Culture-Derived Inactivated Influenza Vaccine1


• Optimized immunogenicity with >95% seroprotection rates against all strains in adults and >90% in children ≥3 years2-3
• Tolerable safety profiles in adults and children ≥3 years2-3
• Contains no eggs, no preservatives and no antibiotics1

References:
1. Korea Ministry of Food and Drug Safety. [http://www.mfds.go.kr/eng/brd/m_30/view.do?seq=70648]. Accessed July 24, 2018.
2. Choi WS, Noh JY, Song JY, et al. Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects. Hum Vaccin Immunother 2017; 13(7): 1653-1660.
3. Kim YK, Eun BW, Lee TJ, et al. Immunogenicity and Safety of a Cell Culture-Derived Inactivated Quadrivalent Influenza Vaccine (NBP607-QIV) in South Korean Children and Adolescents: A Randomized, Double-Blind, Multi-Center, Phase 3 Clinical Trial. Open Forum Infect Dis 2016; Vol 3(Suppl 1): 763.

Further information is available in section 12b, New In This Issue and mims.com
Full prescribing information is available upon request.                                                                                                                                                                                                                                                                                                MY-SCF-000001-08/18

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 6 days ago
Early administration of recombinant human B-type natriuretic peptide (rhBNP) can lower the incidence of reperfusion injury for patients with ST-elevation myocardial infarction (STEMI) who are receiving percutaneous coronary intervention (PCI) treatment, according to a China study.
11 Aug 2019
Intraoperative methylprednisolone does not appear to significantly prevent the incidence of death, cardiac arrest and other injuries in neonates undergoing cardiac surgery with cardiopulmonary bypass, according to a recent study.
3 days ago
Pulmonary function has potential predictive value for future increases in arterial stiffness and its progression, as reported in a recent study.
Yesterday
Systolic blood pressure appears to have a strong association with aneurysmal subarachnoid haemorrhage (aSAH) but not with unruptured intracranial aneurysm (UIA), whereas current smoking and female sex are risk factors for both conditions, a study has found.